Design Therapeutics, Inc. (DSGN)
15.55
+1.33
(+9.35%)
USD |
NASDAQ |
May 11, 16:00
15.55
0.00 (0.00%)
After-Hours: 17:45
Design Therapeutics Market Cap : 971.21M for May 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| vTv Therapeutics, Inc. | 119.93M |
| Immuneering Corp. | 337.07M |
| X4 Pharmaceuticals, Inc. | 424.44M |
| ACADIA Pharmaceuticals, Inc. | 3.734B |
| Alnylam Pharmaceuticals, Inc. | 38.03B |
Market Cap Related Metrics
| PEG Ratio | -0.6403 |
| Price to Book Value | 4.454 |
| Price | 15.55 |
| Earnings Yield | -7.68% |
| PEGY Ratio | -0.6403 |